Frequency of anticardiolipin, antinuclear and anti β2GP1 antibodies is not increased in unselected epileptic patients: A case-control study

Seizure

Volumn 13, Issue 4, 2004, Pages 205-207

  Debourdeau, Philippe ^a   Gérome, Patrick ^a   Zammit, Christine ^a   Saillol, Anne ^b   Aletti, Marc ^a   Bargues, Laurent ^b   Cointet, François ^b  

^a HIA Desgenettes   (France)

^b PERCY MILITARY HOSPITAL   (France)

Author keywords

Anticardiolipin antibodies; Antinuclear antibodies; Epilepsy

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOCAL EPILEPSY; FREQUENCY ANALYSIS; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEUROIMAGING; PATIENT SELECTION; PRIORITY JOURNAL; SEIZURE;

EID: 2342667613     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00112-2     Document Type: Article

References (18)

1. Levin, S. R. and Welsch, K. M. A. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Archives of Neurology 1987; 44: 876-883.
2. Harris, E. N. and Hughes, G. R. V. Cerebral disease in SLE. Springer Seminars in Immunopathology 1985; 8: 251-266.
3. Tan, E. M., Cohen, A. S., Fries, J. F. et al. The 1992 revised criteria for classification of systemic lupus erythematosus. Arthritis and Rheumatism 1982; 25: 1271-1277.
4. Toubi, E., Khamashta, M. A., Panarra, A. and Hughes, G. R. V. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. American Journal of Medicine 1995; 99: 397-401.
5. Herranz, M. T., Rivier, G., Khamashta, M. A., Blaser, K. U. and Hughes, G. R. V. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis and Rheumatism 1994; 37: 568-571.
6. Liou, H. H., Wang, C. R., Chen, C. J. et al. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5: 305-312.
7. Verrot, D., San Marco, D., Dravet, C. et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. American Journal of Medicine 1997; 103: 33-37.
8. Peltola, J. T., Haapala, A. M., Isojärvi, J. I. et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. American Journal of Medicine 2000; 109: 712-717.
9. Ranua, J. A., Luoma, K., Peltola, J. T., Haapala, A. M. and Isojärvi, J. I. Autoantibodies in patients with epilepsy. A cohort based study. Epilepsia 2001; 42 (S2): 20.
10. Eriksson, K., Peltola, J., Keranen, T., Haapala, A. M. and Koivikko, M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Research 2001; 46: 129-137.
11. Cimaz, R., Romeo, A., Scarano, A. et al. Prevalence of anticardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 2002; 43: 52-59.
12. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34: 592-596.
13. Vila, P., Hernandez, M. C., Lopez-Fernandez, M. F. and Batlle, J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thrombosis and Haemostasis 1994; 72: 209-213.
14. Tan, E. M., Feltkamp, T. E., Smolen, J. S. et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis and Rheumatism 1997; 40: 1601-1611.
15. Armitage, P. and Berry, G. Statistical Methods in Medical Research. Oxford, Blackwell Scientific Publications, 1987.
16. Aarli, J. A. Epilepsy and the immune system. Archives of Neurology 2000; 57: 1689-1692.
17. Chapman, J., Cohen-Armon, M., Shoenfeld, Y. and Korczyn, A. D. Antiphospholipid antibodies permeabilize and depolarized brain synaptoneurosomes. Lupus 1999; 8: 127-133.
18. Villari, F. and Avanzini, G. The use of immunoglobulins in the treatment of human epilepsy. Neurological Sciences 2002; 23 (S1): S33-S37.